Biotest Aktiengesellschaft (BIO) — Cash Flow-to-Debt Ratio
Biotest Aktiengesellschaft (BIO) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2025, meaning its operating cash flow of €-58.10 Million could theoretically repay 0% of its total liabilities (€906.90 Million) in one year. See financial flexibility index of Biotest Aktiengesellschaft to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotest Aktiengesellschaft Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Biotest Aktiengesellschaft across 23 annual periods. For the full cash flow conversion analysis, see Biotest Aktiengesellschaft cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Biotest Aktiengesellschaft (2002–2024)
Year-by-year debt coverage analysis for Biotest Aktiengesellschaft. Check cash flow quality index of Biotest Aktiengesellschaft to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | €60.90 Million | €903.30 Million | ▲ +2377.3% |
| 2023 | 0.00x | €-2.70 Million | €912.00 Million | ▲ +93.9% |
| 2022 | -0.05x | €-40.50 Million | €831.90 Million | ▼ -203.9% |
| 2021 | 0.05x | €33.90 Million | €723.80 Million | ▲ +293.4% |
| 2020 | -0.02x | €-16.70 Million | €689.70 Million | ▲ +54.5% |
| 2019 | -0.05x | €-33.60 Million | €631.50 Million | ▲ +41.8% |
| 2018 | -0.09x | €-50.00 Million | €547.10 Million | ▼ -268.0% |
| 2017 | 0.05x | €34.30 Million | €630.70 Million | ▼ -52.8% |
| 2016 | 0.12x | €65.90 Million | €572.10 Million | ▲ +66.4% |
| 2015 | 0.07x | €38.10 Million | €550.40 Million | ▲ +435.4% |
| 2014 | -0.02x | €-11.40 Million | €552.40 Million | ▼ -22.0% |
| 2013 | -0.02x | €-7.20 Million | €425.80 Million | ▼ -115.2% |
| 2012 | 0.11x | €34.73 Million | €312.91 Million | ▼ -48.4% |
| 2011 | 0.22x | €72.28 Million | €336.09 Million | ▼ -10.3% |
| 2010 | 0.24x | €77.83 Million | €324.73 Million | ▲ +175.1% |
| 2009 | 0.09x | €31.68 Million | €363.59 Million | ▼ -14.4% |
| 2008 | 0.10x | €34.49 Million | €338.67 Million | ▼ -2.6% |
| 2007 | 0.10x | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €198.12 Million | ▲ +41.5% |
| 2004 | 0.10x | €25.29 Million | €250.31 Million | ▲ +50.9% |
| 2003 | 0.07x | €16.52 Million | €246.69 Million | ▲ +610.6% |
| 2002 | 0.01x | €2.46 Million | €261.20 Million | — |